Remarkably, 75.9% of Taiwanese CBAVD patients tested carry at least one variant in SLC9A3 or CFTR, suggesting that CBAVD likely arises from independent or cumulative effects of CFTR and SLC9A3 deficiency. The gene discussed is SLC9A3; the disease is congenital bilateral aplasia of vas deferens from CFTR mutation.